January 11, 2017

TAPUR Trial Targets Individual Cancers with Treatments Outside of FDA-approved Indication

Researchers have launched a new study designed to broaden access to drugs for some patients with advanced cancers and to collect and share data on individual responses to drugs that have not yet been approved for their specific cancer types. The Targeted Agent and Profiling Utilization Registry (TAPUR) study is for patients who had genomic […]

Read More

November 14, 2016

5 Things You Need to Know About Lung Cancer

In recent years, Ashish Sangal, MD, a medical oncologist at Cancer Treatment Centers of America® (CTCA), has noticed more patients have come to initial consultation appointments with a fair amount of background knowledge about lung cancer. “Because social media and the internet make information so easily available, I’ve seen that significantly increase,” says Dr. Sangal, […]

Read More

November 13, 2016

6 Top Myths About Pancreatic Cancer

Although it’s estimated that more than 53,000 Americans will be diagnosed with pancreatic cancer in 2016, many people are misinformed about the disease. In honor of Pancreatic Cancer Awareness Month, we’ve debunked the top six pancreatic cancer myths. Myth #1 – Pancreatic cancer is always deadly. Contrary to what some believe, pancreatic cancers can be […]

Read More

October 11, 2016

Double Duty

In the past, women requiring mastectomy for breast cancer typically faced a series of operations and recoveries. But now patients may be able to opt for simultaneous surgeries, which can give better cosmetic results including less scarring. Before undergoing any type of breast reconstruction surgery, it’s important understand what it involves and get answers to […]

Read More
blood cancers 550 x550

September 14, 2016

Lymphoma, Leukemia, Myeloma: Hope on the Horizon

Advances in diagnosing and treating blood cancers have helped double survival rates, and the future outlook may be even brighter. Blood cancers—lymphoma, leukemia and myeloma—made up almost 10 percent of all cancer cases diagnosed in 2015, or about 162,000 new cancer cases. At the same time, progress is being made on the survival front. More […]

Read More

August 4, 2016

Playing Defense

You probably think of your immune system as your body’s natural defense against external infections, or that thing you try to boost during flu season. But as a former laboratory researcher who explored using the immune system to fight diseases, I’ve seen firsthand how its elegant signaling pathways can be modified to better fight cancer. […]

Read More
Genetics background. 3D render.

August 4, 2016

Precision Treatment: Studies Show Hope on the Horizon

The Claim:  Patients who received precision treatment—in which doctors used drugs targeting their specific DNA mutations—saw tumor shrinkage at rates six times greater than those who were given regular chemotherapy. The interval of time before their cancer continued growing was also nearly twice as long. The Study: Researchers at the University of California, San Diego Health […]

Read More
Illustration of lymphocytes attacking a cancer cell. Natural killer cells are a type of lymphocyte that destroys cancer cells and other altered cells by releasing cytotoxic granules.

May 24, 2016

Immunotherapy: Studies Show Hope on the Horizon

The Claim: The body’s immune system can be activated to combat certain tumors—including sarcomas, cancers that occur in connective tissues—using a combination of immunotherapy and chemotherapy. The Study: In Phase I of the PembroPlus study that began in January 2015, pembrolizumab was administered to a small group of patients to evaluate its safety, determine safe […]

Read More
hand holding a tube test

May 23, 2016

B-12 Deficiencies: Studies Show Hope on the Horizon

The Claim: Evaluating methylmalonic acid (MMA) and homocysteine (HC) rather than vitamin B-12 alone can better identify cancer patients with functional B-12 deficiencies. The Study: In 2014, a group of 316 patients at Cancer Treatment Centers of America® at Midwestern Regional Medical Center were tested. All patients were evaluated at baseline for vitamin B-12, methylmalonic […]

Read More
Robert Hauer

May 23, 2016

The Missing LinQ: Technology on the Horizon

Big data gives us a mountain of facts and figures. Our challenge: putting that information to use in a way that improves patient care—now and for years to come. CancerLinQ™, a new initiative from the American Society of Clinical Oncology (ASCO), is a technology platform that allows large amounts of anonymous health care data to […]

Read More
1 2 3